Novel drug may provide hope for blood cancer patients 

Scientists have developed a new drug that has the potential to strip cancer cells of their “immortality”, a finding that could help in treating patients suffering from one of the most aggressive forms of leukaemia.

Read also:Turmeric can be used to fight cancer in children!

HXR9 Treatment:

• Acute myeloid leukemia (AML) is a type of cancer of the blood and bone marrow with excess immature white blood cells and is responsible for 265,000 worldwide cases each year.
• The drug candidate, called HXR9, works by preventing the cancer cells from sidestepping the natural process that causes unhealthy and damaged cells to die known as apoptosis.

Read also:Gene therapy may treat diabetes and obesity via skin!

• “Acute myeloid leukaemia is a pretty intractable disease and doesn’t respond to many treatments. This is a novel therapeutic target that hasn’t been shown before to be effective against this form of leukaemia,” said Richard Morgan, Professor at the University of Bradford in the UK.
• The drug targets a particular family of genes, called HOX genes, which helps to give cancer cells the ability to continuously grow and divide.
• HXR9 was found to strip the cancer cells of this ability by turning off the HOX genes, Morgan said.

Read also:Breast cancer treatment successfully stops tumour growth

According to a Study:

• In the study, published in the journal Oncotarget.
• The team analysed gene expression data from 269 AML patients.
•  Found an association between the activity of a group of HOX genes and the patient survival rate.
• When HXR9 was tested on cancerous cells, they underwent a process known as necroptosis.
• Necroptosis causes the cells to explode and spew their contents into the bloodstream.
• Rather than simply digesting themselves as normally occurs in apoptosis.
• This increases the likelihood that there will be a subsequent immune reaction against the cancer cells, Morgan noted.
• In addition, HXR9 “could well be used in combination treatments but the initial trials will be as a single therapy”.

Read also:Eating chocolate may provide relief from bowel disease